Items tagged with Treatment
TB drug affects vision in some patients (post)
A study, jointly conducted by Medecins Sans Frontiers (MSF) and Lilavati Hospital in Mumbai, has shown that some anti-tuberculosis drugs can have adverse effects on the eye, and can even lead to compromised vision in patients.
How one organisation is helping Indians with extremely drug-resistant TB get the help they need (post)
An article published in the Better India describes what Médecins Sans Frontières does for patients with extremely drug-resistant TB in India. The article is about one of those patients in Mumbai. Click here to read it and watch a short video.
Tradeoffs in introduction policies for the TB drug bedaquiline: a model-based analysis (post)
Abstract
Two women, one drug: a failure of compassion in the global response to drug-resistant TB (post)
Fatima and Asa, two women in their early thirties, might never have met if life had been more kind to them both. Asa was finishing nursing school while living a middle-class life with her husband and three young children in a two-story home in the capital city. Fatima was a mother of five who grew up in deep poverty and was still struggling for survival in a one-room shack on the outskirts of town.
Severe adverse events during second-line TB treatment in the context of high HIV co-infection in South Africa: a retrospective cohort study (post)
Abstract
Making child friendly TB medicines available: a game changer for India (post)
Global Fund and USAID financing supports procurement of the new pediatric formulation in India through the Stop TB Partnership’s Global Drug Facility
MSF reports on use of the new TB drugs bedaquiline and delamanid (post)
Access to the new TB drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continue.
India: New drugs, new hope (post)
Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for TB patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available.
High-dose rifampicin, moxifloxacin, and SQ109 for treating TB: a multi-arm, multi-stage randomised controlled trial (post)
Summary
MSF offers access to new TB drug in SA (post)
After feeling ill for months, 16-year-old Sinethemba Kuse received the news that she had multidrug-resistant tuberculosis (MDR-TB) from her local clinic in Khayelitsha outside of Cape Town in December last year.
Page 25 of 108 · Total posts: 0
←First 24 25 26 Last→